Ex vivo NMR metabolomics approach using cerebrospinal fluid for the diagnosis of primary CNS lymphoma: Correlation with MR imaging characteristics
Open Access
- 8 August 2022
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 12 (4) , 4679-4689
Abstract
Purpose: Primary central nervous system lymphoma (PCNSL) is an uncommon extranodal non‐Hodgkin's lymphoma. Here, the feasibility of nuclear magnetic resonance (NMR) metabolomics for the diagnosis and prognosis prediction of PCNSL, as well as its correlation with magnetic resonance imaging (MRI) characteristics, was assessed.Patients and Methods: Cerebrospinal fluid (CSF) samples from PCNSL and normal groups (n = 41 for each) were obtained along with MRI data including pre‐ and postcontrast as well as T1‐, T2‐, and diffusion‐weighted imaging for the treatment‐naïve PCNSL patients (n = 24). The CSF samples were analyzed using nuclear magnetic resonance (NMR).Results: The CSF NMR metabolomic exhibited clear differences with a diagnostic sensitivity of 100% and a specificity of 97.6%. The citrate level of the leptomeningeal enhancement (LE) (+) group was significantly lower than that of the LE (−) group (p = 0.018). In addition, the MRI apparent diffusion coefficient (ADC) value of the tumor was positively correlated with the glucose level (p = 0.025). However, none of the marker metabolites were significant prognosis predictors in univariate analysis.Conclusions: In conclusion, the NMR metabolomics could be helpful to diagnose PCNSL, but not for the prognosis, and MRI features (LE or ADC) can reflect the metabolic profiles of PCNSL.Keywords
Funding Information
- National Research Foundation of Korea (NRF‐2016M3C7A1914002, NRF‐2018R1A3B1052328, NRF‐2020R1A2C2008949, NRF‐2020R1A4A1018714, NRF‐2020R1A6A3A01099440)
- Seoul National University (IBS‐R006‐A1)
This publication has 48 references indexed in Scilit:
- Lactate: A Metabolic Key Player in CancerCancer Research, 2011
- Elevated citrate in pediatric astrocytomas with malignant progressionNeuro-Oncology, 2011
- Metabolic management of brain cancerBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2011
- The metabolic advantage of tumor cellsMolecular Cancer, 2011
- Q's next: the diverse functions of glutamine in metabolism, cell biology and cancerOncogene, 2009
- Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt SignalingCancer Research, 2009
- Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed GlioblastomaJournal of Clinical Oncology, 2009
- Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR‐MAS spectroscopy of biopsy tissuesMagnetic Resonance in Medicine, 2008
- Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989–2003Cancer, 2007
- Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter studyJournal of Neurosurgery, 1996